Vita Coco (COCO) CEO exercises options and sells 25,000 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Vita Coco Company, Inc. director and Chief Executive Officer Martin Roper reported an option exercise and related share sale. He exercised a non-qualified stock option to acquire 25,000 shares of common stock at $10.178 per share, then sold 25,000 shares of common stock at $50.00 per share in an open-market transaction effected under a Rule 10b5-1 trading plan.
Following these transactions, he directly holds 298,484 shares of common stock and retains multiple non-qualified stock options over additional shares with exercise prices between $10.178 and $32.78 expiring between 2031 and 2035. He also has indirect ownership of common stock through the Christopher G. Roper, Peter S. Roper, and Thomas L. Roper Exempt Family Trusts and through his spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 25,000 shares ($1,250,000)
Net Sell
13 txns
Insider
Roper Martin
Role
Chief Executive Officer
Sold
25,000 shs ($1.25M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (Right to Buy) | 25,000 | $0.00 | -- |
| Exercise | Common Stock | 25,000 | $10.178 | $254K |
| Sale | Common Stock | 25,000 | $50.00 | $1.25M |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (Right to Buy) — 425,214 shares (Direct);
Common Stock — 323,484 shares (Direct);
Common Stock — 215,631 shares (Indirect, by Chris Roper FT)
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. These shares are held by the Christopher G. Roper Exempt Family Trust. These shares are held by the Peter S. Roper Exempt Family Trust. These shares are held by the Thomas L. Roper Exempt Family Trust. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The stock option vests in four equal annual installments beginning on March 3, 2026.
Key Figures
Option exercise shares: 25,000 shares
Exercise price: $10.178 per share
Shares sold: 25,000 shares
+5 more
8 metrics
Option exercise shares
25,000 shares
Non-qualified stock option exercised on 2026-04-16 at $10.178
Exercise price
$10.178 per share
Non-qualified stock option for Vita Coco common stock
Shares sold
25,000 shares
Open-market sale of common stock at $50.00 per share
Sale price
$50.00 per share
Common stock sale on 2026-04-16
Direct common shares after
298,484 shares
Direct Vita Coco common stock held after transactions
Option at $15.00
298,507 underlying shares
Non-qualified stock option expiring 2031-10-21
Option at $32.78
70,715 underlying shares
Non-qualified stock option expiring 2035-03-03
Indirect holding (Chris Roper FT)
215,631 shares
Common stock held by Christopher G. Roper Exempt Family Trust
Key Terms
Non-Qualified Stock Option (Right to Buy), Rule 10b5-1 trading plan, Exempt Family Trust, open-market sale, +1 more
5 terms
Non-Qualified Stock Option (Right to Buy) financial
"security_title: "Non-Qualified Stock Option (Right to Buy)""
Rule 10b5-1 trading plan financial
"The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Exempt Family Trust financial
"These shares are held by the Christopher G. Roper Exempt Family Trust."
open-market sale financial
"transaction_action: "open-market sale" for 25,000 common shares at $50.0000"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
vests in four equal annual installments financial
"The stock option vests in four equal annual installments beginning on March 10, 2024."
FAQ
What insider transaction did COCO CEO Martin Roper report on this Form 4?
Martin Roper reported exercising a non-qualified stock option for 25,000 Vita Coco shares and then selling 25,000 common shares. The option exercise converted derivative rights into stock, and the sale was an open-market transaction disclosed in this Form 4 filing.
What stock option did COCO’s CEO exercise and at what exercise price?
He exercised a non-qualified stock option (right to buy) covering 25,000 shares of Vita Coco common stock at an exercise price of $10.178 per share. This option was fully vested and currently exercisable, as described in the filing’s footnotes.
Does the COCO CEO still hold stock options after this Form 4 transaction?
Yes. Martin Roper retains several non-qualified stock options over Vita Coco common shares, with exercise prices of $10.178, $15.00, $16.91, $26.18, and $32.78, expiring between 2031 and 2035, indicating a continuing derivative-based equity position in the company.